Knee gel injection aims to ease arthritis pain without surgery

NCT ID NCT06611098

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This clinical trial tests a gel called ABIO3419, injected into the knee joint, to see if it safely reduces pain and improves function in people with knee osteoarthritis. The study compares ABIO3419 to another treatment and measures pain relief over three months. Participants are adults aged 35 to 85 with moderate knee osteoarthritis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ABIO3419 (viscosupplement gel)

What this could lead to

If it works, this could offer a safe, non-surgical option to reduce knee pain and improve mobility for people with osteoarthritis.

What could go wrong

This is an early-stage trial with 134 participants, so results may not apply to everyone. Possible side effects include temporary pain, swelling, or joint discomfort at the injection site.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRISTIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Locations

  • IRIS CRO

    Mtskheta, 3300, Georgia

  • IRIS CRO

    Riga, 1002, Latvia